Scientific publications

New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD

Seijo LM (1,2), Soriano JB (2,3), Peces-Barba G (2,4).

(1) Clínica Universidad de Navarra, Madrid, Spain.
(2) Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, CIBERES, Instituto de Salud Carlos III, Madrid, Spain.
(3) Hospital Universitario La Princesa, Madrid, Spain.
(4) IIS - Fundación Jiménez Díaz, Madrid, Spain.

Magazine: The European Respiratory Journal

Date: Jun 5, 2019

Lung Cancer Area Pneumology

Not long ago, chronic obstructive pulmonary disease (COPD) was considered a Cinderella, an unappealing disease lacking therapeutic options. It was also stigmatised as a consequence of the smoking habit that is a leading cause of COPD worldwide [1]. However, as the Global Initiative for Chronic Obstructive Lung Disease (GOLD) [2], and the joint American Thoracic Society/European Respiratory Society consensus documents suggest [3], COPD should be viewed as treatable and preventable, offering multiple opportunities for disease modification.

CITATION  Eur Respir J. 2019 Jun 5;53(6). pii: 1900717. doi: 10.1183/13993003.00717-2019

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra